Radioimmunoassay for Glutamic Acid Decarboxylase (GAD65) Autoantibodies as a Diagnostic Aid for Stiff-Man Syndrome and a Correlate of Susceptibility to Type 1 Diabetes Mellitus
- 1 December 1998
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 73 (12) , 1161-1166
- https://doi.org/10.4065/73.12.1161
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 1997
- Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetesNature, 1993
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- Autoantibodies to Glutamic Acid Decarboxylase in a Patient with Stiff-Man Syndrome, Epilepsy, and Type I Diabetes MellitusNew England Journal of Medicine, 1988
- Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes.Journal of Clinical Investigation, 1987
- Immunology and Diabetes Workshops: report of the first international workshop on the standardisation of cytoplasmic islet cell antibodiesDiabetologia, 1986
- Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin TreatmentScience, 1983
- Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteinsNature, 1982
- ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIESThe Lancet, 1974
- IMMUNOPHARMACOLOGICAL DISEASE: A BREAK IN TOLERANCE TO RECEPTOR SITESThe Lancet, 1971